Zytiga
NDC 57894-150, abiraterone acetate, tablet, from Janssen Biotech, Inc..
- Product NDC
- 57894-150
- Status
- Listed
- Labeler
- Janssen Biotech, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA202379
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/57894-150 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ABIRATERONE ACETATE250 mg/1
Pharmacologic classes
Cytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57894-150-12 | 57894015012 | 120 TABLET in 1 BOTTLE (57894-150-12) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4e338e89-3cf2-48eb-b6e2-a06c608c6513
Use it
Look up 57894-150 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57894-150 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57894-150. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.